Lenea

Ethinylestradiol and Gestodene, the active ingredients in Lenea, are a combined oral contraceptive presented as an oral tablet for systemic use. They are prescribed to prevent pregnancy and may also be used to manage menstrual cycle disorders in women of reproductive age.

GNH USA supplies Lenea as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch. Our distribution network ensures timely delivery across EU, Asia, Africa and the Americas.

Lenea, a combined oral contraceptive, acts on the hormonal regulation of the reproductive system.

Contraception: prevents pregnancy by inhibiting ovulation and altering cervical mucus. Menstrual cycle regulation: provides more predictable bleeding patterns and reduces dysmenorrhea. Acne management: decreases androgen‑driven skin lesions in women.

Lenea may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild stomach upset, often transient. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: swelling or discomfort of the breasts. - Irregular bleeding: spotting or breakthrough bleeding between periods.

Serious or Rare Side Effects: - Venous thromboembolism: deep vein thrombosis or pulmonary embolism, requiring immediate medical attention. - Hypertensive crisis: sudden high blood pressure, especially in women with pre‑existing hypertension. - Allergic reaction: rash, itching, swelling, or anaphylaxis.

Before prescribing Lenea, clinicians should consider several precautionary measures to ensure patient safety.

Medical history review: assess for thromboembolic disorders, cardiovascular disease, liver dysfunction, or hormone‑sensitive cancers. Smoking status: avoid use in women over 35 who smoke, due to increased clot risk. Concurrent medications: evaluate for drugs that induce hepatic enzymes, which may reduce contraceptive effectiveness. Pregnancy testing: confirm non‑pregnant status before initiating therapy. Follow‑up monitoring: schedule periodic assessments of blood pressure and menstrual patterns. Store at ambient temperature: keep tablets below 25 °C in the original packaging, protected from moisture and light.

Lenea can interact with other medicines, altering its effectiveness or increasing adverse risk.

Major Interactions (Avoid): - Enzyme inducers (e.g., rifampicin, carbamazepine, phenytoin): may markedly reduce contraceptive efficacy. - Antifungal azoles (e.g., ketoconazole): can increase hormone levels, raising risk of side effects.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): hormonal changes may affect INR, requiring dose adjustment. - Antidepressants (e.g., sertraline): may increase risk of mood changes, monitor patient. - Herbal supplements (e.g., St. John’s wort): may lower contraceptive effectiveness, advise caution.